Zacks Investment Research on MSN6h
FDA Approves Novartis Drug for Rare Kidney Disease Treatment
Novartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved ...
Novartis23h
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
People22d
Anti-Aging Pill for Dogs Certified as 'Effective' by FDA. But Could It Work for Humans, Too?
The anti-aging pill still needs to earn a safety and manufacturing certification by the FDA in order to by approved Kimberlee Speakman is a digital writer at PEOPLE. She has been working at PEOPLE ...
WRIC25d
FDA approves first opioid-free painkiller in over two decades
RICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.
The Baltimore Sun11d
RFK Jr. has it wrong — the FDA approves too few drugs
To some pundits and politicians, the Food and Drug Administration (FDA) recklessly approves medications that harm patients while padding the pockets of shareholders. For example, the new Health ...
Alnylam's Amvuttra Gets Approval for Expanded Indication From FDA
Alnylam Pharmaceuticals' amyloidosis drug Amvuttra received Food and Drug Administration approval for an expanded indication.